早期帕金森病的冲动-强迫行为是由冷漠和多巴胺受体D3多态度决定的
Hendrik Theis1,2, Stéphane Prange1,3, Gérard N Bischof1,4
1Faculty of Medicine and University Hospital Cologne, Department of Nuclear Medicine, Multimodal Neuroimaging Group, University of Cologne, 50937, Cologne, Germany.
NPJ Parkinson's disease
|November 16, 2023
概括
无情和多巴胺受体D3 (DRD3) 基因变异是早期帕金森病中冲动-强迫行为 (ICB) 的危险因素. 无动于衷可能会使患者在多巴胺治疗后倾向于ICB,由DRD3风险变体放大.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 精神病学是一个精神病学.
背景情况:
- 冲动-强迫行为 (ICB) 和冷漠是早期帕金森病 (PD) 的常见非运动症状.
- 这两种情况都与边缘性多巴胺基系统有关,这表明共享的病理生理机制.
- 多巴胺受体D3 (DRD3) Ser9Gly多态性影响了边缘性条纹体中多巴胺受体的亲和力.
研究的目的:
- 调查ICB,冷漠和DRD3基因多态性在早期PD之间的关系.
- 检查冷漠和DRD3基因型对灰质体积和多巴胺合成能力的影响.
- 了解多巴胺替代疗法后ICB发展的诱导因素.
主要方法:
- 54名早期PD患者接受了MRI,以评估灰质体积.
- 40名患者用[18F]DOPA进行PET成像,以测量条纹性多巴胺合成能力.
- DRD3 Ser9Gly (rs6280) 多态性被基因定型,并使用验证的尺度来评估ICB/无能症严重程度.
主要成果:
- ICB严重程度与冷漠度严重程度正相关.
- 无动于衷和DRD3多态性作为ICB的危险因素相互作用.
- 无动于衷与双边膜缩和边缘条状膜的多巴胺合成能力降低有关;DRD3风险变体在膜和边缘条状膜中显示了减少的多巴胺合成.
结论:
- 药物原始的PD患者的冷漠可能源于条性多巴胺基基调的受损,可能使他们容易患上ICB.
- 由于较高的多巴胺亲和力,DRD3风险变体可能会放大这种倾向.
- 这些发现突出了帕金森病中冷漠,遗传和ICB之间的复杂相互作用.
相关概念视频
Parkinson's Disease: Treatment
278
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
278
Parkinson's Disease: Overview
560
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
560
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Human Genetics
586
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
586
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K


